TRIPHASE

About TRACER Europe

TRACER Europe is a pioneering imaging CRO that leverages Phase 0 microdosing and molecular imaging to de-risk and accelerate drug development for biopharma sponsors. Its core service involves labeling a sponsor's drug candidate (antibody, small molecule, peptide, etc.) to visualize and quantify its behavior in human patients at a very early stage, enabling critical go/no-go decisions before costly traditional trials. Founded in 2018, the private company operates in a high-growth niche, helping clients reduce development costs and timelines by providing human proof-of-concept data faster than conventional pathways.

Therapeutic Areas

Other Not Specified Drugs